ID: ALA4104868

Max Phase: Preclinical

Molecular Formula: C23H22N4O2

Molecular Weight: 386.46

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cn1c(-c2ccc(CN3CCCC3)cc2)nc2onc(-c3ccccc3)c2c1=O

Standard InChI:  InChI=1S/C23H22N4O2/c1-26-21(18-11-9-16(10-12-18)15-27-13-5-6-14-27)24-22-19(23(26)28)20(25-29-22)17-7-3-2-4-8-17/h2-4,7-12H,5-6,13-15H2,1H3

Standard InChI Key:  SSCRINYPNCWOPT-UHFFFAOYSA-N

Associated Targets(Human)

dCTP pyrophosphatase 1 562 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 386.46Molecular Weight (Monoisotopic): 386.1743AlogP: 3.85#Rotatable Bonds: 4
Polar Surface Area: 64.16Molecular Species: BASEHBA: 6HBD: 0
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 0#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 9.13CX LogP: 3.69CX LogD: 1.95
Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.53Np Likeness Score: -1.35

References

1. Llona-Minguez S, Häggblad M, Martens U, Johansson L, Sigmundsson K, Lundbäck T, Loseva O, Jemth AS, Lundgren B, Jensen AJ, Scobie M, Helleday T..  (2017)  Diverse heterocyclic scaffolds as dCTP pyrophosphatase 1 inhibitors. Part 2: Pyridone- and pyrimidinone-derived systems.,  27  (15): [PMID:28655422] [10.1016/j.bmcl.2017.06.039]

Source